首页|注射用益气复脉联合阿托伐他汀对冠心病心绞痛气虚血瘀证患者凝血功能和血液流变学的影响

注射用益气复脉联合阿托伐他汀对冠心病心绞痛气虚血瘀证患者凝血功能和血液流变学的影响

扫码查看
目的 观察注射用益气复脉联合阿托伐他汀对冠心病心绞痛气虚血瘀证患者凝血功能指标和血液流变学的影响.方法 选取2022年1月至2023年1月青岛市胶州中心医院收治的冠心病心绞痛气虚血瘀证患者256例,按随机数表法将其分为对照组(阿托伐他汀治疗)和研究组(注射用益气复脉联合阿托伐他汀治疗),各128例.治疗14 d后,比较两组临床疗效,比较两组治疗前后中医症状积分、心绞痛情况(周发作次数、单次发作持续时间)、凝血功能[纤维蛋白原(FIB)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)]、血液流变学指标(全血高切黏度、全血低切黏度、血浆黏度、红细胞比容、血小板聚集率),记录治疗期间两组不良反应发生情况.结果 研究组临床疗效优于对照组(P<0.05).治疗后,两组各项中医症状积分、周发作次数、FIB、全血高切黏度、全血低切黏度、血浆黏度、红细胞比容、血小板聚集率均低于治疗前,且研究组低于对照组(P<0.05).治疗后,两组单次发作持续时间、PT、APTT、TT均短于治疗前,且研究组PT、APTT、TT短于对照组(P<0.05).两组治疗期间均未发生明显不良反应.结论 注射用益气复脉联合阿托伐他汀能够缓解冠心病心绞痛患者临床症状和心绞痛发作情况,可能与改善患者凝血功能和血液流变学指标相关.
Effect of Yiqi Fumai for injection combined with Atorvastatin on coagula-tion function and hemorheology in coronary heart disease patients with angina pectoris with syndrome of blood stasis due to qi deficiency
Objective To observe the effect of Yiqi Fumai for injection combined with Atorvastatin on coagulation function and hemorheology in coronary heart disease patients with angina pectoris with syndrome of blood stasis due to qi deficiency.Methods A total of 256 coronary heart dis-ease patients with angina pectoris with syndrome of blood stasis due to qi deficiency were selected from Jiaozhou Central Hospital of Qingdao from January 2022 to January 2023,and they were divided into control group(Atorvastatin treatment)and study group(Yiqi Fumai for injection com-bined with Atorvastatin treatment)according to random number table method,with 128 cases in each group.After 14 days of treatment,the clinical efficacy of the two groups was compared.Traditional Chinese medicine symptom score,angina pectoris(weekly attack number,duration of single at-tack),coagulation function(fibrinogen[FIB],prothrombin time[PT],activated partial thromboplastin time[APTT],and thrombin time[TT]),hemorheological indexes(whole blood high tangential viscosity,whole blood low tangential viscosity,plasma viscosity,hematocrit,and platelet ag-gregation rate)were compared between the two groups before and after treatment,and the occurrence of adverse reactions in the two groups during treatment were recorded.Results The clinical effect of the study group was better than that of the control group(P<0.05).After treatment,the scores of traditional Chinese medicine symptoms,weekly attack number,FIB,whole blood high tangential viscosity,whole blood low tangential vis-cosity,plasma viscosity,hematocrit,and platelet aggregation rate in both groups were lower than those before treatment,and those of study group were lower than those of control group(P<0.05).After treatment,the duration of single attack,PT,APTT,and TT in both groups were shorter than those before treatment,and PT,APTT,and TT of study group were shorter than those of control group(P<0.05).No obvious adverse reactions oc-curred in both groups during treatment.Conclusion Yiqi Fumai for injection combined with Atorvastatin can relieve clinical symptoms and angina pectoris in coronary heart disease patients with coronary heart disease,which may be related to improving coagulation function and hemorheology indexes.

Angina pectoris of coronary heart diseaseYiqi Fumai for injectionAtorvastatinBlood coagulation functionHemorheology

王春良、仲宝华、石淑贞、李明

展开 >

青岛市胶州中心医院心血管内科,山东青岛 266300

青岛市胶州中心医院临床药学科,山东青岛 266300

山东省临沂市人民医院心内科,山东临沂 276002

冠心病心绞痛 注射用益气复脉 阿托伐他汀 凝血功能 血液流变学

山东省自然科学基金面上项目

ZR2020MH018

2024

中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
年,卷(期):2024.21(14)
  • 1
  • 12